Back
Edgewise Therapeutics Stock Predictions

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
40
EWTX
Edgewise Therapeutics
Last Price:
$14.37
Seasonality Move:
-3.88%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaEdgewise Therapeutics Stock Forecast
-
Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 10.7% based on the past 4 years of stock performance.
-
Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Edgewise Therapeutics Stock Undervalued?The current Edgewise Therapeutics [EWTX] share price is $14.33. The Score for EWTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
EWTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Edgewise Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 10.7% based on the past 4 years of stock performance.
Edgewise Therapeutics Stock Rating
Sell
40
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics overpriced?
-
Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Edgewise Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com
52-Week Data
52-Week High:
38.12
52-Week Low:
10.60
Prediction Charts
Market Cap:
1.5B
Price in USD:
14.33
Volume:
474.8K
Beta:
0.29
Technical Analysis
SMA50:
14.70
SMA100:
19.20
SMA200:
24.03
52-Wk Change:
-17.6%
Stock Predictions
-
Is Edgewise Therapeutics stock public?Yes, Edgewise Therapeutics is a publicly traded company.
-
What is the Edgewise Therapeutics stock quote today?The Edgewise Therapeutics stock price is 14.33 USD today.
-
How to buy Edgewise Therapeutics stock online?You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-5 | 14.47 | 14.82 | 14.90 | 14.16 |
Jun-6 | 15.11 | 15.24 | 15.60 | 14.97 |
Jun-9 | 15.57 | 15.26 | 15.69 | 14.86 |
Jun-10 | 15.50 | 15.45 | 15.74 | 15.09 |
Jun-11 | 15.64 | 15.75 | 16.30 | 15.30 |
Jun-12 | 15.60 | 15.42 | 15.68 | 15.11 |
Jun-13 | 15.06 | 15.29 | 15.68 | 15.06 |
Jun-16 | 15.37 | 14.68 | 15.43 | 14.63 |
Jun-17 | 14.44 | 14.49 | 14.94 | 14.39 |
Jun-18 | 14.40 | 14.47 | 14.81 | 14.35 |
Jun-20 | 14.63 | 14.30 | 14.66 | 14.06 |
Jun-23 | 14.20 | 14.18 | 14.40 | 13.78 |
Jun-24 | 14.30 | 14.75 | 14.85 | 14.06 |
Jun-25 | 14.78 | 14.33 | 14.78 | 14.18 |
Edgewise Therapeutics Earnings
Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Edgewise Therapeutics Forecast Revenue Growth
Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.22 per share.
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.